Organisation · GOV.UK transparency returns · sha1:9dc3610f5fa64256f74994b16244362864135d31
Lord Kamall,�DHSC, Minister for Technology, Innovation and Life Sciences, Office of Life Sciences, Oxford University, NHS England, Medical Research Council, UK Research and Innovation, UK Biobank, Innovate UK, Cambridge University, Wellcome Trust, NHS Digital, Medicine Manufacturing Industries Partnership, Association of the British Pharmaceutical Industry, Association of British HealthTech Industries, BioIndustry Association, Science Industry Partnership, Legal & General, Merck Sharp & Dohme Ltd, Johnson & Johnson�Innovation, AstraZeneca, United California Bank - UCB, SV Health Investors, GSK, Life Sciences British Patient Capital, British Business Bank, Office for Investment
- Identity
organisation:govuk:sha1:9dc3610f5fa64256f74994b16244362864135d31— the GOV.UK transparency returns key, used as-is. No identity here is invented.- Graph built
- 5 September 2026
Names in the records
Each spelling a register uses for this entity, and the method that tied it here. A name is never the identity; a similar name is never a match.
| As published | Register | Tied by | Confidence | Rows |
|---|
What the records establish
- Lord Kamall,�DHSC, Minister for Technology, Innovation and Life Sciences, Office of Life Sciences, Oxford University, NHS England, Medical Research Council, UK Research and Innovation, UK Biobank, Innovate UK, Cambridge University, Wellcome Trust, NHS Digital, Medicine Manufacturing Industries Partnership, Association of the British Pharmaceutical Industry, Association of British HealthTech Industries, BioIndustry Association, Science Industry Partnership, Legal & General, Merck Sharp & Dohme Ltd, Johnson & Johnson�Innovation, AstraZeneca, United California Bank - UCB, SV Health Investors, GSK, Life Sciences British Patient Capital, British Business Bank, Office for Investment: 1 record of "recorded meeting with a minister" on 21 October 2021.
| Relationship | With | Date | Amount | Detail | Record |
|---|---|---|---|---|---|
| recorded meeting with a minister | George Freeman | 21 October 2021 | — | ministerial_meetings |
What this does not establish
The records above establish that Lord Kamall,�DHSC, Minister for Technology, Innovation and Life Sciences, Office of Life Sciences, Oxford University, NHS England, Medical Research Council, UK Research and Innovation, UK Biobank, Innovate UK, Cambridge University, Wellcome Trust, NHS Digital, Medicine Manufacturing Industries Partnership, Association of the British Pharmaceutical Industry, Association of British HealthTech Industries, BioIndustry Association, Science Industry Partnership, Legal & General, Merck Sharp & Dohme Ltd, Johnson & Johnson�Innovation, AstraZeneca, United California Bank - UCB, SV Health Investors, GSK, Life Sciences British Patient Capital, British Business Bank, Office for Investment and each entity named appear together in an official register, in the relationship that register records, on the date it records. They do not establish why any donation was made, why any contract was awarded, whether any one record was known to the people behind another, or that any record caused another. No causal inference is made on this page, and nothing here is a finding of any kind against anyone. A reported donation is a lawful, reported transaction; a contract award is a published notice; a seat is a seat.
Derived from: ministerial_meetings. Each row above names the table and key it came from and links the official record where one exists. How the graph is built is described at the evidence graph.